RBP4 and breast cancer: As shown in Figure 3A, we found that high expressions of SFRP1, SAA1 and RBP4 were related to favorable long-term survival in BC patients, while high expression of KIF4A, UBE2C and COL11A1 was associated with poor prognosis in BC patients (Figure 3B).